van Dijken, B.R.J.; Doff, A.R.; Enting, R.H.; van Laar, P.J.; Jeltema, H.-R.; Dierckx, R.A.J.O.; van der Hoorn, A.
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More? Cancers 2023, 15, 4973.
https://doi.org/10.3390/cancers15204973
AMA Style
van Dijken BRJ, Doff AR, Enting RH, van Laar PJ, Jeltema H-R, Dierckx RAJO, van der Hoorn A.
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More? Cancers. 2023; 15(20):4973.
https://doi.org/10.3390/cancers15204973
Chicago/Turabian Style
van Dijken, Bart R. J., Annerieke R. Doff, Roelien H. Enting, Peter Jan van Laar, Hanne-Rinck Jeltema, Rudi A. J. O. Dierckx, and Anouk van der Hoorn.
2023. "Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?" Cancers 15, no. 20: 4973.
https://doi.org/10.3390/cancers15204973
APA Style
van Dijken, B. R. J., Doff, A. R., Enting, R. H., van Laar, P. J., Jeltema, H.-R., Dierckx, R. A. J. O., & van der Hoorn, A.
(2023). Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More? Cancers, 15(20), 4973.
https://doi.org/10.3390/cancers15204973
